ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015).

Daisaku YamadaShogo KobayashiHidenori TakahashiYoshifumi IwagamiHirofumi AkitaKei AsukaiJunzo ShimizuTerumasa YamadaMasahiro TanemuraShigekazu YokoyamaMasanori TsujieTadafumi AsaokaYutaka TakedaOsakuni MorimotoAkira TomokuniYuichiro DokiHidetoshi Eguchi

Published in: Annals of surgical oncology (2024)

Keyphrases

locally advanced
neoadjuvant chemotherapy
rectal cancer
squamous cell carcinoma
radiation therapy
sentinel lymph node
advanced non small cell lung cancer
double blind
epidermal growth factor receptor
liver metastases